Adrada Beatriz Elena, Karbasian Niloofar, Huang Monica, Rauch Gaiane Maia, Woodtichartpreecha Piyanoot, Whitman Gary
Department of Breast Imaging, MD Anderson, Houston, Texas, United States.
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
J Clin Imaging Sci. 2021 Nov 9;11:58. doi: 10.25259/JCIS_113_2021. eCollection 2021.
The purpose of this study is to determine the biological markers more frequently associated with recurrence in the reconstructed breast, to evaluate the detection method, and to correlate recurrent breast cancers with the detection method.
An institutional review board-approved retrospective study was conducted at a single institution on 131 patients treated with mastectomy for primary breast cancer followed by breast reconstruction between 2005 and 2012. Imaging features were correlated with clinical and pathologic findings.
Of the 131 patients who met our inclusion criteria, 40 patients presented with breast cancer recurrence. The most common histopathologic type of primary breast cancer was invasive ductal carcinoma in 82.5% (33/40) of patients. Triple-negative breast cancer was the most common biological marker with 42.1% (16/38) of cases. Clinically, 70% (28/40) of the recurrences presented as palpable abnormalities. Of nine patients who underwent mammography, a mass was seen in eight patients. Of the 35 patients who underwent ultrasound evaluation, an irregular mass was found in 48.6% (17/35) of patients. Nine patients with recurrent breast cancer underwent breast MRI, and MRI showed an irregular enhancing mass in four patients, an oval mass in four patients, and skin and trabecular thickening in one patient. About 55% of patients with recurrent breast cancer were found to have distant metastases.
Patients at higher risk for locoregional recurrence may benefit from imaging surveillance in order to detect early local recurrences.
本研究旨在确定与重建乳房复发更常相关的生物学标志物,评估检测方法,并将复发性乳腺癌与检测方法相关联。
在单一机构进行了一项经机构审查委员会批准的回顾性研究,研究对象为2005年至2012年间因原发性乳腺癌接受乳房切除术并随后进行乳房重建的131例患者。影像特征与临床和病理结果相关联。
在符合我们纳入标准的131例患者中,40例出现乳腺癌复发。原发性乳腺癌最常见的组织病理学类型是浸润性导管癌,占患者的82.5%(33/40)。三阴性乳腺癌是最常见的生物学标志物,占病例的42.1%(16/38)。临床上,70%(28/40)的复发表现为可触及的异常。在接受乳腺钼靶检查的9例患者中,8例发现有肿块。在接受超声评估的35例患者中,48.6%(17/35)的患者发现有不规则肿块。9例复发性乳腺癌患者接受了乳腺MRI检查,MRI显示4例患者有不规则强化肿块,4例患者有椭圆形肿块,1例患者有皮肤和小梁增厚。约55%的复发性乳腺癌患者被发现有远处转移。
局部区域复发风险较高的患者可能受益于影像监测,以便早期发现局部复发。